Zivo Bioscience Inc. Warrants (ZIVOW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Zivo Bioscience Inc. Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Zivo Bioscience Inc. Warrants (ZIVOW) has returned -69.24% so far this year and -94.62% over the past 12 months.

Based on dividend-adjusted daily data since May 28, 2021, ZIVOW's average daily return is +2.39%, while the average monthly return is +25.68%. At this rate, your investment would double in approximately 0.3 years.

Historically, 38% of months were positive and 62% were negative. The best month was Jan 2024 with a return of +1,500.0%, while the worst month was Oct 2025 at -78.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, ZIVOW closed higher 25% of trading days. The best single day was Jan 2, 2024 with a return of +425.0%, while the worst single day was Nov 4, 2025 at -94.3%.

Zivo Bioscience Inc. Warrants has an annualized alpha of 34703.43%, beta of 1.05, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since June 01, 2021.

• This stock participated in 169.52% of S&P 500 Index downside but only -60.02% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ZIVOW ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Zivo Bioscience Inc. Warrants (ZIVOW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Zivo Bioscience Inc. Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zivo Bioscience Inc. Warrants was 99.04%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Zivo Bioscience Inc. Warrants drawdown is 97.98%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Zivo Bioscience Inc. Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Zivo Bioscience Inc. Warrants is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.